You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
Novapak Sinus Packing and Stent
Novapak™ is a single use, dissolvable nasal packing and stent for use following sinus surgery. It’s been designed to control bleeding and prevent adhesions while providing antibacterial effectiveness in a moist wound healing environment.1-4
DIscover how the Novapak™ Nasal Sinus Packing and Stent optimizes wound healing after functional endoscopic sinus surgery (FESS).
Novapak™ Nasal Sinus Packing and Stent is designed to deliver meaningful therapeutic benefits and antibacterial effectiveness to support postoperative healing.1-4
The Novapak™ sponge is placed in the middle meatus of the nasal cavity and physically separates the mucosal tissue surfaces as a stent and, in turn, aids in preventing adhesion formation. Upon application, Novapak™ acts as a hemostatic aid by minimizing bleeding and oozing of the debrided mucosal surfaces via a tamponade effect, blood absorption, and stimulation of platelet aggregation.
Novapak™ hydrates with sterile saline and forms a gel. The packing dissolves within the nasal cavity with daily irrigation and natural mucus flow over several days. Residence time is typically 7-14 days with adequate irrigation. Alternately, the packing may be removed through gentle aspiration at the discretion of the physician.
Novapak™ is pliable, compressible, springs back when hydrated, and easily manipulated during placement. One sponge can be used in a bilateral procedure by cutting or tearing. Offered in standard and firm configurations for optimal support, stability and density, enabling surgeons to tailor therapy.1,2
Novapak™ Standard | Novapak ™ Firm | |
---|---|---|
CFN Number |
CS3600-10 (10pk) |
CS3900-10 (10pk) |
Sizes |
8cm x 1.8cm x 1.3cm |
8cm x 1.8cm x 1.3cm |
Residence Time |
7-14 days |
7-14 days (Novapak™ Firm dissolves slower than Novapak™ Standard. Therefore, it provides stenting capabilities for a longer period of time.) |
Structural Support |
Up to 48 hours |
Up to 48 hours |
Absorption Capacity |
Up to 32 times its weight |
Up to 32 times its weight |
Material |
Chitosan Hydrochloride and Cellulose |
Chitosan Hydrochloride and Cellulose |
Storage Temperature |
At room temperature |
At room temperature |
Chitosan is a polymer produced from chitin, a component of the hard external shell of shellfish. Its hemostatic properties have been extensively studied in civilian and military clinical settings.1-4
Novapak is contraindicated in patients with known shellfish allergies.
Medtronic offers more than 5,000 products and instruments for ENT specialists.
BROWSE CATALOG
800-874-5797
Rao SB and Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997; 34:21-28.
Malette WG, Quigley H, Gaines RD, Johnson ND, Rainer G. Chitosan: a new hemostatic. Ann Thorac Surg. 1983; 36:55-58.
Chou TC, Fu E, Wu CJ, Yeh JH. Chitosan enhances platelet adhesion and aggregation. Biochem Biophys Res Commun. 2003; 302:480-483.
Dutkiewicz JK. Superabsorbent materials from shellfish waste–a review. J Biomed Mater Res. 2002; 63:373-381.
Costain, D.J., Kennedy, R., Ciona, C.J., McAlister, V.C., & Lee, T.D. (1997). Prevention of postsurgical adhesions with N,O-carboxymethylchitosan: examination of the most efficacious preparation and the effect of N,O-carboxymethyl chitosan on postsurgical healing. Surgery, 121 3, 314-9.
Li L, Wang N, Jin X, et al. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid-based hydrogels for postoperative adhesion prevention. Biomaterials. 2014; 35:3903-3917.
Kourelis K and Shikani AH. Effectiveness of chitosan-based packing in 35 patients with recalcitrant epistaxis in the context of coagulopathy. Clin Otolaryngol. 2012; 37(4):309-313.
Shikani AH, Chahine KA, Alqudah MA. Endoscopically guided chitosan nasal packing for intractable epistaxis. Am J Rhinol Allergy. 2011; 25(1):61-63.
Internal Data Available.
FDA 510K, K202623.510K Summary Final
Athanasiadis, T., Beule, A., Robinson, B.H., Robinson, S.R., Shi, Z., & Wormald, P.J. “Effects of a novel chitosan gel on mucosal wound healing following endoscopic sinus surgery in a sheep model of chronic rhinosinusitis”. The Laryngoscope, 2008 Jun; 118 (6): 1088-94.
Valentine R, Athanasiadis T, Moratti S, Hanton L, Robinson S, Wormald PJ. “The efficacy of a novel chitosan gel on hemostasis and wound healing after endoscopic sinus surgery”. Am J Rhinol Allergy. 2010 Jan-Feb;24(1):70-5.